Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

Healthcare Medical Devices
MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Medx Health Corp > SNN PRESENTATION
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(680)
•••
Comment by Dunworkin2on Dec 20, 2021 1:32pm
135 Views
Post# 34247496

RE:RE:RE:RE:SNN PRESENTATION

RE:RE:RE:RE:SNN PRESENTATION

hopefull wrote:
Mike indicated they got paid about 77k for the Netherlands and that they are now complete on their trial and moving into commercialization. The point here is that dermsecure is revenue producing finally. So yes blast off once the larger investment comminity recognizes this. Mentioning a deal in the us which I believe is new. And here is the big piece of news that not sure who is paying attention but mdx shipped 41 units to Brazil. Meaning that deal is now moving and not dead. This in my opinion is what we all have been waiting for. Mike is finally speaking to revenue.

 

Not seeing any siascopy locations marked in Brazil on the Mdx "Get Scanned" website map. Must be stuck in transit?

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities